Webcast
The Journey Toward Paperless Clinical Trials
To view the media player you will need Adobe Flash!
Download Adobe Flash
Download Adobe Flash
The video player is loading...
Pharma companies are seeking to bolster pipelines and cut costs more than ever before in preparation for looming patent expirations of blockbuster drugs. In this environment global collaborations are increasing while budgets are shrinking, and as a result Internet-based communication has taken a prominent position in clinical development.
In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.
Discussion includes:
In contrast to the rapid changes in the structure of development teams and the advancements in web-based communications tools, the progress toward completely paperless clinical trials has been notably slow. Are we about to turn the corner and see new momentum? In over two decades since the first remote data entry systems were introduced, interfaces and speed of computer-based systems have improved greatly, yet the challenges of managing the paper distribution, collection and management of clinical regulatory documents in clinical trials persists.
Discussion includes:
- The push for paperless continues: A look at the latest trends and initiatives
- Clinical studies end-to-end: Which parts of the process are farthest along and which have the highest hurdles
- Who benefits? Views on the benefits and burdens of transitioning to paperless for sites, sponsors, regulators and others
- Where from here? Practical next steps towards the paperless trial
More Webcasts
Whistleblowing, Bounty Hunting, and Retaliation: New Compliance Challenges for your Organization
This webcast will provide in house counsel, compliance professionals, and HR with an overview of:
- The latest whistleblower protection laws, including heightened FCPA enforcement and how the Dodd-Frank corporate whistleblower program is turning employees into bounty hunters.
- Anti-retaliation protections, including recent cases that have changed both the breadth and scope of retaliation claims.
- Practical strategies and best practices for organizations to mitigate skyrocketing whistleblower and retaliation risk.
On-Demand Video Webcast: Intellectual Property M&A
mergermarket, in association with IntraLinks, hosted the live webcast, Intellectual Property M&A. The webcast will discuss some the importance of Intellectual Property as a driver of M&A.
Podcast: Quarterly M&A Update
In this latest quarterly podcast, mergermarket and IntraLinks assembled a panel of transatlantic dealmakers to discuss what influenced M&A from April to September. After a bumper first half for global deal volumes, Q3 saw the market hit by a wave of uncertainty over sovereign debt and sluggish global economic growth. But what was our panel’s impression of the market?
IntraLinks for Alternative Investment Fund Administrators: Collaborating to Increase the Top and Bottom Lines
Discover how IntraLinks can help Fund Administrators capitalize on emerging opportunities while controlling their costs. The presentation will walk you through the IntraLinks solutions and capabilities Fund Administrators are leveraging to expand their service suite, engage earlier with prospects and attract large self administered funds that are moving to 3rd party administration.
Strengthening Sponsor/CRO and Clinical Research Site Connections
Understand how the use of extended enterprise collaboration technologies is helping the clinical research community gain operational efficiencies and strengthen relationships between clinical research sites and Sponsors/CROs. Hear firsthand how clinical research sites interact, correspond, collaborate and share information with Sponsor Organizations, and their perceived challenges with their current methods.
Did You Know?
IntraLinks also offers:
Success Story
immatics biotechnologies
Cancer drug developer immatics biotechnologies prides itself on open communication. Using IntraLinks to manage due diligence, immatics showed investors they could trust the company. What resulted was the largest private biotech financing round in Germany since 2001. In the process, immatics saved time and resources, and gave investors an efficient way to review information.